EXACT SCIENCES CORP (EXAS) Stock Income Statement
NASDAQ:EXAS - Nasdaq - US30063P1057 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.83B | 2.76B | 2.50B | 2.08B | 1.77B | |||
| Cost Of Goods | 876.29M | 840.15M | 737.56M | 574.40M | 458.80M | |||
| Gross Profit | 1.95B | 1.92B | 1.76B | 1.51B | 1.31B | |||
| Operating Expenses | 2.12B | 2.10B | 1.98B | 2.09B | 2.06B | |||
| Research and Development | 425.91M | 427.91M | 425.93M | 393.40M | 300.30M | |||
| Selling, General, and Administrative Expenses | 1.65B | 1.67B | 1.62B | 1.58B | 1.66B | |||
| Operating Income | -166.76M | -179.24M | -214.39M | -577.50M | -750.20M | |||
| Interest Income/Expense | -963.00K | 2.29M | 2.94M | -39.10M | 13.20M | |||
| Non Recurring Items | -861.01M | -859.21M | 9.70M | -16.00M | -105.50M | |||
| Income Before Taxes | -1.03B | -1.04B | -201.75M | -632.60M | -842.50M | |||
| Income Tax | -8.89M | -7.30M | 2.40M | -9.10M | -246.90M | |||
| Net Income | -1.02B | -1.03B | -204.15M | -623.50M | -595.60M | |||
| EBITDA | 48.22M | 35.62M | -7.78M | -379.90M | -569.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.50 | -5.59 | -1.13 | -3.54 | -3.48 | |||
| Non GAAP EPS | -5.51 | -5.57 | -1.14 | -3.43 | -3.46 | |||
| Statistics | ||||||||
| Gross Profit Margin | 69.02% | 69.55% | 70.49% | 72.44% | 74.04% | |||
| Profit Margin | -36.06% | -37.29% | -8.17% | -29.91% | -33.70% | |||
| Operating Profit Margin | -5.90% | -6.50% | -8.58% | -27.71% | -42.45% | |||
All data in USD